Dysport Therapeutic Approved by Health Canada for Lower Limb Spasticity Treatment in Adults
News
AbobotulinumtoxinA, marketed as Dysport Therapeutic by Ipsen Biopharmaceuticals Canada, was approved by Health Canada for the treatment of lower limb focal spasticity in adults. Focal spasticity is a medical disorder ... Read more